12-2610660-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_000719.7(CACNA1C):​c.3678C>G​(p.Phe1226Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,614,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. F1226F) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 missense

Scores

8
6
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:2

Conservation

PhyloP100: 0.328

Publications

2 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.832

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.3828C>G p.Phe1276Leu missense_variant Exon 29 of 50 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 48 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.3843C>G p.Phe1281Leu missense_variant Exon 29 of 48 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.3738C>G p.Phe1246Leu missense_variant Exon 29 of 49 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 48 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 48 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.3768C>G p.Phe1256Leu missense_variant Exon 28 of 47 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.3768C>G p.Phe1256Leu missense_variant Exon 28 of 47 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.3768C>G p.Phe1256Leu missense_variant Exon 28 of 47 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.3768C>G p.Phe1256Leu missense_variant Exon 28 of 47 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 48 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.3753C>G p.Phe1251Leu missense_variant Exon 29 of 48 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.3738C>G p.Phe1246Leu missense_variant Exon 29 of 48 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.3753C>G p.Phe1251Leu missense_variant Exon 29 of 47 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 46 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 46 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 46 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 47 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.3669C>G p.Phe1223Leu missense_variant Exon 28 of 47 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.3678C>G p.Phe1226Leu missense_variant Exon 28 of 46 ENSP00000507309.1 Q13936-19
CACNA1CENST00000480911.6 linkn.*2285C>G non_coding_transcript_exon_variant Exon 26 of 27 5 ENSP00000437936.2 F5H638
CACNA1CENST00000480911.6 linkn.*2285C>G 3_prime_UTR_variant Exon 26 of 27 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152228
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000399
AC:
1
AN:
250764
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000880
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1461880
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
2
AN XY:
727240
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1112010
Other (OTH)
AF:
0.00
AC:
0
AN:
60392
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.00109982), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152228
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41468
American (AMR)
AF:
0.00
AC:
0
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5196
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Apr 08, 2017
Stanford Center for Inherited Cardiovascular Disease, Stanford University
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:provider interpretation

Our patient is a 14 year-old with paroxysmal atrial fibrillation. He was tested at Invitae. p.Phe1226Leu (c.3678C>G) in exon 28 of the CACNA1C gene (NM_000719.6; ENST00000399655.5) Chromosome position 12:2719826 C / G We classify this as a Variant of Uncertain Significance (VUS), concluding that there is not sufficient evidence for its pathogenicity to warrant using it for diagnosis or predictive genetic testing. This is a rare variant that has not been reported in the literature in association with disease. It is present in just one individual in population databases (gnomAD). The CACNA1C gene is associated with autosomal dominant Timothy syndrome (TS), also known as long QT syndrome (LQTS) type 8 (MedGen UID: 331395), Brugada syndrome (BrS) (MedGen UID: 395633), and short QT syndrome (SQTS) (MedGen UID: 378835). This is a conservative amino acid change, resulting in the replacement of a nonpolar phenylalanine with a nonpolar leucine. Phenylalanine at this location is absolutely conserved across all ~100 vertebrate species for which we have data. No missense variation at nearby residues (+/- 10) is listed in ClinVar as Likely Pathogenic or Pathogenic as of 4/8/2017. According to the Invitae report, in silico analysis programs do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In total the variant has been seen in 1 out of 123,132 individuals from publicly available population datasets. Specifically, it was reported in 1/55,856 non-Finnish European ancestry individuals whose exomes are in the gnomAD database. There is no other reported missense variation at this codon. gnomAD includes variant calls on ~140,000 individuals of European, African, Latino, South Asian, Ashkenazi, and East Asian descent. Our patient’s ancestry is Northern European Caucasian. There is good sequencing coverage at this site. The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. The curators made an effort to exclude individuals with severe pediatric diseases. -

Long QT syndrome Uncertain:1
Nov 27, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 1226 of the CACNA1C protein (p.Phe1226Leu). This variant is present in population databases (rs775309900, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 411725). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNA1C protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
CardioboostArm
Uncertain
0.75
BayesDel_addAF
Pathogenic
0.37
D
BayesDel_noAF
Pathogenic
0.29
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.66
D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;T;.;.
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.51
FATHMM_MKL
Uncertain
0.95
D
M_CAP
Pathogenic
0.54
D
MetaRNN
Pathogenic
0.83
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.67
D
MutationAssessor
Uncertain
2.2
.;.;.;.;.;.;.;.;.;.;.;M;M;.;.;.;.;.;.;.;.;.;.;.
PhyloP100
0.33
PrimateAI
Pathogenic
0.89
D
PROVEAN
Pathogenic
-5.5
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.
REVEL
Pathogenic
0.71
Sift
Benign
0.11
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;.
Sift4G
Benign
0.15
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.94, 0.98, 0.98, 0.68, 1.0, 0.97, 1.0, 0.79, 0.98, 0.95, 0.99, 0.99
.;P;D;D;P;D;D;D;D;P;D;D;P;D;P;D;.;D;P;.;.;.;D;.
Vest4
0.85
MutPred
0.43
.;.;.;.;.;.;.;.;.;.;.;Gain of catalytic residue at I1249 (P = 0.0016);Gain of catalytic residue at I1249 (P = 0.0016);.;.;.;.;.;.;.;.;.;.;.;
MVP
0.93
MPC
1.3
ClinPred
0.98
D
GERP RS
-3.6
gMVP
0.96
Mutation Taster
=38/62
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs775309900; hg19: chr12-2719826; API